Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.
In vivo electroporation (EP) has been shown to augment the immunogenicity of plasmid DNA vaccines, but its mechanism of action has not been fully characterized. In this study, we show that in vivo EP augmented cellular and humoral immune responses to a human immunodeficiency virus type 1 Env DNA vaccine in mice and allowed a 10-fold reduction in vaccine dose. This enhancement was durable for over 6 months, and re-exposure to antigen resulted in anamnestic effector and central memory CD8(+) T-lymphocyte responses. Interestingly, in vivo EP also recruited large mixed cellular inflammatory infiltrates to the site of inoculation. These infiltrates contained 45-fold-increased numbers of macrophages and 77-fold-increased numbers of dendritic cells as well as 2- to 6-fold-increased numbers of B and T lymphocytes compared to infiltrates following DNA vaccination alone. These data suggest that recruiting inflammatory cells, including antigen-presenting cells (APCs), to the site of antigen production substantially improves the immunogenicity of DNA vaccines. Combining in vivo EP with plasmid chemokine adjuvants that similarly recruited APCs to the injection site, however, did not result in synergy.
Liu
Jinyan
J
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Kjeken
Rune
R
Mathiesen
Iacob
I
Barouch
Dan H
DH
D000256:Adenoviridae / Q000235:genetics / Q000276:immunology; D000276:Adjuvants, Immunologic; D000818:Animals; D000938:Antigen-Presenting Cells / Q000166:cytology* / Q000276:immunology*; D002465:Cell Movement / Q000276:immunology*; D049109:Cell Proliferation; D018925:Chemokines / Q000235:genetics / Q000276:immunology; D018274:Electroporation; D015497:HIV-1 / Q000276:immunology*; D007125:Immunogenetics; D051379:Mice; D008807:Mice, Inbred BALB C; D010641:Phenotype; D010957:Plasmids / Q000235:genetics; D019444:Vaccines, DNA / Q000235:genetics* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D018925:Chemokines; D019444:Vaccines, DNA